Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
GlaxoSmithKline Pharmaceuticals Limited (NSE: GLAXO), ISIN INE159A01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
GLAXO last traded at ₹2700.90 (+6.97%), with a 52-week range of ₹2088.10 to ₹3120.70 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 75.00%, FIIs 4.75%, DIIs 8.47%, mutual funds 6.07%.
EquiSense Score (ECS): 71/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.